Results of another study have shown that serum glutathione levels were significantly reduced in the serum of NAFLD patients, while there were enhanced levels of ALT and the DNA oxidation marker 8-hydroxy-2-deoxyguanosine (8-OHdG). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.